Number of patients who were provided with the service with the main diagnosis C34 (lung cancer) or the main diagnosis Z51 and the comorbid diagnosis C34, and the value of benefits: Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Go back to [[Poland]] page | |||
'''Type of Information''': Year; Sex; Age group; Type of benefit; Refund value and number of patients. | '''Type of Information''': Year; Sex; Age group; Type of benefit; Refund value and number of patients. | ||
Revision as of 18:59, 16 June 2023
Go back to Poland page
Type of Information: Year; Sex; Age group; Type of benefit; Refund value and number of patients.
Source of Information: Data prepared on the basis of data from the National Health Fund headquarters as of 2021-11-09.
Data level: National.
Number of Records: Unknown.
Date Range: 2013-2020.
Cancer Areas of Interest: Malignant neoplasm of bronchia and lung (C34); Encounter for other aftercare and medical care (Z51).
Open data access: Publicly available [1].
Information/Contact for data request: Contact information [2].
